Alpha Synuclein News Today

New study reveals the link between Lewy body pathology and brain bleeds in Alzheimers patients, highlighting the need for better diagnostic tools and treatment

The Movement Disorders Foundation of Arizona (MDFA) will host an educational seminar at the Fountain Hills Community Center on Saturday, Sept. 2, from 9 a.m. to 12 p.m. Dr. Padma Mahant, M.D. and Dr. …

The Movement Disorders Foundation of Arizona (MDFA) will host an educational seminar at the Fountain Hills Community Center on Saturday, Sept. 2, from 9 a.m. to 12 p.m. Dr. Padma

According to a new study using technology created by a researcher at UTHealth Houston, the presence of a misfolded alpha-synuclein protein can be used to assess whether people have Parkinsons disease

The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol.

Vikram Khurana discussed recent advances and new, individualized approaches to Parkinson’s, as well as implications of the recent findings.

Copper modifies and accelerates alpha synuclein aggregation, offering potential inroads to novel methods of detecting and treating Parkinsons disease, new research suggests.

PHILADELPHIA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering...

World Parkinson Coalition Spotlights Research in New Series The World Parkinson Coalition (WPC) launches reportedly its first-ever WPC Research Spotlight series. The series includes six interviews in 2021 with renowned Parkinson scientists, during which they further explain their research and what it could mean for the Parkinson community. Every 3 years at the World Parkinson Congress, the WPC brings together basic scientists, neurologists, clinical researchers, general physicians, nurses, re...